Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) Price to Sales (2011 - 2026)

Analysis

Abeona Therapeutics (ABEO) Price to Sales (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.08
Mar 31, 2026 29.22
Dec 31, 2025 53.52
Jun 30, 2025 727.72
Jun 30, 2023 24.73
Dec 31, 2022 356.08
Jun 30, 2022 30.82
Mar 31, 2022 3,400.69
Dec 31, 2020 1,257.72
Sep 30, 2020 307.88
Dec 31, 2018 23,192.66
Sep 30, 2018 8,977.32
Jun 30, 2018 69,483.02
Mar 31, 2018 31,960.02
Dec 31, 2017 123,862.75
Sep 30, 2017 91,040.88
Jun 30, 2017 29,704.89
Mar 31, 2017 27,053.15
Dec 31, 2016 19,065.83
Sep 30, 2016 27,126.22